다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Freeline Therapeutics Holdings PLC (FRLN)
Freeline Therapeutics Holdings PLC (FRLN) 뉴스

FRLN

Freeline Therapeutics (FRLN)

Freeline Therapeutics Holdings PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FRLN

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/04/25	05:00	GlobeNewswire Inc.	Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/26	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/23	06:38	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/23	06:36	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/23	06:33	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/23	06:32	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/23	06:28	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/21	05:22	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/20	21:13	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/20	21:00	GlobeNewswire Inc.	Acquisition of Freeline by Syncona Becomes Effective	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/13	06:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/02/13	02:00	GlobeNewswire Inc.	Freeline Shareholders Approve Acquisition by Syncona	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/01/19	06:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2024/01/18	06:17	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/12/09	07:21	Edgar (US Regulatory)	Form SC 13E3 - Going private transaction by certain issuers	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/12/01	22:56	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/11/22	23:20	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/11/22	21:30	GlobeNewswire Inc.	Syncona to Acquire Freeline Therapeutics	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/10/25	19:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/10/25	15:01	GlobeNewswire Inc.	Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/10/18	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/10/16	20:00	GlobeNewswire Inc.	Freeline to Present New Clinical Data for FLT201 in Gaucher Disease in Oral Presentation at Upcoming ESGCT 30th Annual Congress	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/10/07	05:52	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/10/04	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/10/04	20:00	GlobeNewswire Inc.	Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/08/15	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/08/15	20:00	GlobeNewswire Inc.	Freeline Reports Second Quarter 2023 Financial Results and Business Highlights	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/08/08	20:30	GlobeNewswire Inc.	Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/07/31	20:30	GlobeNewswire Inc.	Freeline to Participate in Upcoming Investor Conferences	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC
2023/07/25	20:30	GlobeNewswire Inc.	Freeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201, in Gaucher Disease	NASDAQ:FRLN	Freeline Therapeutics Holdings PLC

검색 관련기사 보기:NASDAQ:FRLN

1 2 3 4 5 6 다음 >>

American Express

JP Morgan Chase

Verizon Communications

US Dollar vs Euro

US Dollar vs Sterling

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관